MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 115 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $3,098,465 | +27.2% | 11,603 | +10.2% | 0.00% | +50.0% |
Q4 2023 | $2,435,969 | +55.9% | 10,528 | -1.6% | 0.00% | 0.0% |
Q3 2023 | $1,562,628 | -51.8% | 10,700 | -23.8% | 0.00% | -33.3% |
Q2 2023 | $3,245,319 | +27.7% | 14,049 | +33.9% | 0.00% | 0.0% |
Q1 2023 | $2,541,307 | -12.5% | 10,490 | +4.8% | 0.00% | 0.0% |
Q4 2022 | $2,904,241 | +343.4% | 10,006 | -0.6% | 0.00% | +200.0% |
Q3 2022 | $655,000 | +8.1% | 10,068 | +18.8% | 0.00% | 0.0% |
Q2 2022 | $606,000 | -24.6% | 8,473 | +3.4% | 0.00% | 0.0% |
Q1 2022 | $804,000 | +42.6% | 8,194 | +23.2% | 0.00% | – |
Q4 2021 | $564,000 | -8.3% | 6,653 | -13.7% | 0.00% | – |
Q3 2021 | $615,000 | +2.3% | 7,712 | +25.1% | 0.00% | – |
Q2 2021 | $601,000 | -43.0% | 6,166 | -31.7% | 0.00% | -100.0% |
Q1 2021 | $1,055,000 | -36.7% | 9,022 | -39.8% | 0.00% | 0.0% |
Q4 2020 | $1,667,000 | +36.9% | 14,992 | +46.2% | 0.00% | 0.0% |
Q3 2020 | $1,218,000 | -51.8% | 10,253 | -54.0% | 0.00% | -50.0% |
Q2 2020 | $2,525,000 | +192.6% | 22,296 | +72.4% | 0.00% | +100.0% |
Q1 2020 | $863,000 | -56.5% | 12,933 | -40.7% | 0.00% | 0.0% |
Q4 2019 | $1,986,000 | +172.4% | 21,798 | +157.6% | 0.00% | 0.0% |
Q3 2019 | $729,000 | +6.1% | 8,463 | +29.1% | 0.00% | 0.0% |
Q2 2019 | $687,000 | -21.1% | 6,556 | -5.9% | 0.00% | 0.0% |
Q1 2019 | $871,000 | +9.0% | 6,966 | -1.7% | 0.00% | 0.0% |
Q4 2018 | $799,000 | -35.0% | 7,089 | +23.5% | 0.00% | 0.0% |
Q3 2018 | $1,230,000 | -50.0% | 5,740 | -34.7% | 0.00% | -50.0% |
Q2 2018 | $2,459,000 | +263.2% | 8,788 | +51.7% | 0.00% | +100.0% |
Q1 2018 | $677,000 | +46.5% | 5,793 | +15.0% | 0.00% | – |
Q4 2017 | $462,000 | – | 5,036 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Paulson & Co. | 1,850,000 | $518,296,000 | 38.31% |
Tao Capital Management LP | 130,529 | $36,569,005 | 29.98% |
University of Wisconsin Foundation | 45,730 | $12,811,717 | 14.42% |
AlpInvest Partners B.V. | 84,595 | $23,700,135 | 8.50% |
RTW INVESTMENTS, LP | 1,915,862 | $536,747,898 | 8.31% |
Propel Bio Management, LLC | 43,032 | $12,055,845 | 7.82% |
Avoro Capital Advisors LLC | 2,055,555 | $575,884,289 | 7.67% |
Baker Brothers Advisors | 1,974,590 | $553,201,134 | 7.07% |
Tri Locum Partners LP | 65,352 | $18,309,016 | 4.63% |
TCG Crossover Management, LLC | 149,283 | $41,823,125 | 4.36% |